News
Key Points Merck is seeking ways to prepare for a significant upcoming patent cliff.The company has just announced another ...
While Pfizer's dividend yield is clearly much higher than Merck's, both have relatively attractive yields today. And you ...
Our warm weather season is short, and it’s important to enjoy the outdoors. The point isn’t to be sun-scared — just stay ...
Key Points Healthcare is a complex sector, but some dividend payers have proven incredibly reliable over the long ...
Downing did not respond to a voicemail left at his law office. HHS didn’t reply to a request to make him and Kennedy ...
In addition to these quarterly earnings, Merck & Co., Inc. (NYSE:MRK) has shown its resilience as a dividend stock. The ...
Merck & Company, Inc. (NYSE:MRK) is one of the high-margin pharma stocks to buy now. Jefferies has raised its price target on ...
Merck KGaA said its Ezmekly therapy for people with a rare genetic disorder has received the conditional marketing approval ...
Biotech deals involving assets developed in China are surging, a Jefferies report shows. | Biotech deals involving assets ...
The HHS secretary and four of his advisers earned at least $3.2 million from their work opposing Big Pharma and promoting ...
From J&J to BMS, New Jersey pharmaceutical companies continue to expand and transform through M&A, leadership shifts and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results